Nucleotide metabolism links genetics, immunology and pharmacology. Know the enzyme and the drug that inhibits it.
Defects
- Lesch-Nyhan syndrome: HGPRT deficiency (X-linked); hyperuricemia, gout, self-mutilation and intellectual disability.
- ADA deficiency: accumulation of deoxyadenosine kills lymphocytes; severe combined immunodeficiency; treated with enzyme replacement or gene therapy.
- Orotic aciduria: UMP synthase deficiency, megaloblastic anemia unresponsive to B12 or folate; treat with uridine.
Drugs
Hydroxyurea inhibits ribonucleotide reductase. Methotrexate, trimethoprim and pyrimethamine inhibit dihydrofolate reductase. 5-Fluorouracil inhibits thymidylate synthase. Mycophenolate and ribavirin inhibit IMP dehydrogenase. 6-Mercaptopurine and azathioprine block purine synthesis, and allopurinol raises their levels by blocking xanthine oxidase.
Distinction
Purine synthesis builds the ring on ribose; pyrimidine synthesis builds the ring first and then attaches ribose. Carbamoyl phosphate synthetase II (cytosol) is regulated by UTP.
Keep going in biochemistry and molecular biology
- Molecular genetics techniques: cloning, CRISPR and gene therapy
- Glycolysis and gluconeogenesis: key enzymes and regulation
- Glycogen storage diseases: von Gierke, Pompe, Cori and McArdle
- Lysosomal storage diseases: Gaucher, Tay-Sachs, Niemann-Pick and Fabry